Literature DB >> 15506185

Enantiomeric specificity of methylsulfonyl-PCBs and distribution of bis(4-chlorophenyl) sulfone, PCB, and DDE methyl sulfones in grey seal tissues.

Christina Larsson1, Karin Norström, Ioannis Athanansiadis, Anders Bignert, Wilfried A König, Ake Bergman.   

Abstract

PCB methyl sulfones (MeSO2-PCBs) are lipophilic PCB metabolites of which five of the environmentally relevant meta/para pairs are chiral (i.e., exist as atropisomeric pairs). Methylsulfonyl-DDE (MeSO2-DDE) is a DDE metabolite, while bis(4-chlorophenyl) sulfone (BCPS) is a commercial monomer used for thermoplastic production. All these sulfones are well-known environmental contaminants. In this study, liver, lung, and adipose tissue in grey seals (Halichoerus grypus) from the Baltic Sea, naturally exposed to organochlorines via their food, were analyzed for the compounds mentioned. MeSO2-PCBs, 3-MeSO2-DDE, and BCPS were all found in significantly higher concentrations in the liver than in lung and blubber. Their strong liver retention, represented by a median of 42 microg/g l.w. of sigmaMeSO2-PCBs, has previously been mainly neglected in assessments of exposure. The highest concentrations of PCBs and DDE were still found in the grey seal blubber. The atropisomeric composition of MeSO2-PCB congeners was determined, and their enantiomeric fractions were calculated and compared in blubber, liver, and lung tissues. The enantiomeric specificity was equal in all tissues. A notably high abundance (>94%) was observed for one atropisomer in each chiral MeSO2-PCB pair. The first eluting atropisomer (A1) was dominating for all para-substituted MeSO2-PCBs studied, while the second eluting atropisomers (A2) were as dominant in all meta-substituted MeSO2-PCBs in all samples analyzed. In the liver, as much as 50% of sigmaMeSO2-PCBs consisted of the second eluting atropisomer (A2) of 5-MeSO2-CB149. The results imply that the sulfone group is crucial for the specific liver retention of MeSO2-PCBs, 3-MeSO2-DDE, and BCPS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506185     DOI: 10.1021/es049361v

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  6 in total

1.  Gas chromatographic analysis with chiral cyclodextrin phases reveals the enantioselective formation of hydroxylated polychlorinated biphenyls by rat liver microsomes.

Authors:  Izabela Kania-Korwel; Michael W Duffel; Hans-Joachim Lehmler
Journal:  Environ Sci Technol       Date:  2011-10-19       Impact factor: 9.028

2.  A case study on the application of an expert-driven read-across approach in support of quantitative risk assessment of p,p'-dichlorodiphenyldichloroethane.

Authors:  Lucina E Lizarraga; Jeffry L Dean; J Phillip Kaiser; Scott C Wesselkamper; Jason C Lambert; Q Jay Zhao
Journal:  Regul Toxicol Pharmacol       Date:  2019-02-19       Impact factor: 3.271

Review 3.  Chiral polychlorinated biphenyl transport, metabolism, and distribution: a review.

Authors:  Hans-Joachim Lehmler; Stuart J Harrad; Heinrich Hühnerfuss; Izabela Kania-Korwel; Cindy M Lee; Zhe Lu; Charles S Wong
Journal:  Environ Sci Technol       Date:  2010-04-15       Impact factor: 9.028

Review 4.  Metabolism and metabolites of polychlorinated biphenyls.

Authors:  Fabian A Grimm; Dingfei Hu; Izabela Kania-Korwel; Hans-Joachim Lehmler; Gabriele Ludewig; Keri C Hornbuckle; Michael W Duffel; Åke Bergman; Larry W Robertson
Journal:  Crit Rev Toxicol       Date:  2015-01-28       Impact factor: 5.635

5.  Gas chromatographic separation of methoxylated polychlorinated biphenyl atropisomers.

Authors:  Izabela Kania-Korwel; Sandhya M Vyas; Yang Song; Hans-Joachim Lehmler
Journal:  J Chromatogr A       Date:  2008-08-19       Impact factor: 4.759

Review 6.  Occurrence and distribution of PCB metabolites in blood and their potential health effects in humans: a review.

Authors:  Natalia Quinete; Thomas Schettgen; Jens Bertram; Thomas Kraus
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-19       Impact factor: 4.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.